These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

689 related items for PubMed ID: 34012457

  • 21. Seronegative patients with primary Sjögren's syndrome and non-pSS sicca test positive for anti-SSA/Ro52 and -Ro60 in saliva.
    Kamounah S, Wei F, Park JK, Song YW, Chia D, Wong DTW, Pedersen AML.
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167168. PubMed ID: 38641012
    [Abstract] [Full Text] [Related]

  • 22. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
    Nezos A, Papageorgiou A, Fragoulis G, Ioakeimidis D, Koutsilieris M, Tzioufas AG, Moutsopoulos HM, Voulgarelis M, Mavragani CP.
    J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
    [Abstract] [Full Text] [Related]

  • 23. A re-evaluation of anti-NA-14 antibodies in patients with primary Sjögren's syndrome: Significant role of interferon-γ in the production of autoantibodies against NA-14.
    Uomori K, Nozawa K, Ikeda K, Doe K, Yamada Y, Yamaguchi A, Fujishiro M, Kawasaki M, Morimoto S, Takamori K, Sekigawa I, Chan EK, Takasaki Y.
    Autoimmunity; 2016 Aug; 49(5):347-56. PubMed ID: 27328271
    [Abstract] [Full Text] [Related]

  • 24. IgA immunoglobulin isotype of rheumatoid factor in primary Sjögren's syndrome.
    Maślińska M, Mańczak M, Kwiatkowska B, Ramsperger V, Shen L, Suresh L.
    Rheumatol Int; 2021 Mar; 41(3):643-649. PubMed ID: 33496802
    [Abstract] [Full Text] [Related]

  • 25. Effect of Hydroxychloroquine Treatment on Dry Eyes in Subjects with Primary Sjögren's Syndrome: a Double-Blind Randomized Control Study.
    Yoon CH, Lee HJ, Lee EY, Lee EB, Lee WW, Kim MK, Wee WR.
    J Korean Med Sci; 2016 Jul; 31(7):1127-35. PubMed ID: 27366013
    [Abstract] [Full Text] [Related]

  • 26. Increased METTL3 expression and m6A RNA methylation may contribute to the development of dry eye in primary Sjögren's syndrome.
    Ma J, Wang X, Yang X, Wang X, Tan T, Fang H, Zhong Y, Zhang Q.
    BMC Ophthalmol; 2023 Jun 05; 23(1):252. PubMed ID: 37277716
    [Abstract] [Full Text] [Related]

  • 27. Autoantibody to MDM2: A potential serological marker of primary Sjogren's syndrome.
    Liu Y, Liao X, Wang Y, Chen S, Sun Y, Lin Q, Shi G.
    Oncotarget; 2017 Feb 28; 8(9):14306-14313. PubMed ID: 28147328
    [Abstract] [Full Text] [Related]

  • 28. Severity of clinical dry eye manifestations influences protein expression in tear fluid of patients with primary Sjögren's syndrome.
    Aqrawi LA, Chen X, Jensen JL, Morthen MK, Thiede B, Utheim ØA, Palm Ø, Tashbayev B, Utheim TP, Galtung HK.
    PLoS One; 2018 Feb 28; 13(10):e0205762. PubMed ID: 30312344
    [Abstract] [Full Text] [Related]

  • 29. Risk factors for cardiovascular disease in primary Sjögren's syndrome (pSS): a 20-year follow-up study.
    Santos CS, Salgueiro RR, Morales CM, Castro CÁ, Álvarez ED.
    Clin Rheumatol; 2023 Nov 28; 42(11):3021-3031. PubMed ID: 37402929
    [Abstract] [Full Text] [Related]

  • 30. Is Sjögren's syndrome dry eye similar to dry eye caused by other etiologies? Discriminating different diseases by dry eye tests.
    Garcia DM, Reis de Oliveira F, Módulo CM, Faustino J, Barbosa AP, Alves M, Rocha EM.
    PLoS One; 2018 Nov 28; 13(12):e0208420. PubMed ID: 30507949
    [Abstract] [Full Text] [Related]

  • 31. Oral and ocular manifestations in Sjögren's syndrome.
    Kalk WW, Mansour K, Vissink A, Spijkervet FK, Bootsma H, Kallenberg CG, Roodenburg JL, Nieuw Amerongen AV.
    J Rheumatol; 2002 May 28; 29(5):924-30. PubMed ID: 12022351
    [Abstract] [Full Text] [Related]

  • 32. [Evaluation of ocular surface status and function in primary Sjögren's syndrome with hypothyroidism].
    Yu HZ, Zeng WZ, Wu WY, Yao ZQ, Feng Y.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug 18; 54(4):705-711. PubMed ID: 35950396
    [Abstract] [Full Text] [Related]

  • 33. Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome.
    Traianos EY, Locke J, Lendrem D, Bowman S, Hargreaves B, Macrae V, UK primary Sjögren’s syndrome registry, Tarn JR, Ng WF.
    Rheumatol Int; 2020 Apr 18; 40(4):541-548. PubMed ID: 32047959
    [Abstract] [Full Text] [Related]

  • 34. Association of Systemic Markers of Inflammation with Signs and Symptoms of Dry Eye Disease and Sjogren's Syndrome in the Dry Eye Assessment and Management (DREAM©) Study.
    Hashemi MH, Ambrus JL, Shukla AA, Zhu D, Ying GS, Asbell PA, Dry Eye Assessment and Management (DREAM) Study Research Group.
    Curr Eye Res; 2024 Jun 18; 49(6):574-581. PubMed ID: 38345056
    [Abstract] [Full Text] [Related]

  • 35. Could the complement component C4 or its fragment C4d be a marker of the more severe conditions in patients with primary Sjögren's syndrome?
    Sudzius G, Mieliauskaite D, Siaurys A, Viliene R, Butrimiene I, Characiejus D, Dumalakiene I.
    Rheumatol Int; 2014 Feb 18; 34(2):235-41. PubMed ID: 24166212
    [Abstract] [Full Text] [Related]

  • 36. Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sjögren's syndrome.
    Loureiro-Amigo J, Franco-Jarava C, Perurena-Prieto J, Palacio C, Martínez-Valle F, Soláns-Laqué R.
    Clin Exp Rheumatol; 2021 Feb 18; 39 Suppl 133(6):131-139. PubMed ID: 34919042
    [Abstract] [Full Text] [Related]

  • 37. A single-center study of clinical features of pediatric Sjögren's syndrome.
    Hou L, Wang N, Zhao C, Wang X, Du Y.
    Pediatr Rheumatol Online J; 2023 Oct 13; 21(1):119. PubMed ID: 37833819
    [Abstract] [Full Text] [Related]

  • 38. Sjögren's syndrome in rheumatoid arthritis and progressive systemic sclerosis. A comparative study.
    Andonopoulos AP, Drosos AA, Skopouli FN, Moutsopoulos HM.
    Clin Exp Rheumatol; 1989 Oct 13; 7(2):203-5. PubMed ID: 2736835
    [Abstract] [Full Text] [Related]

  • 39. Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.
    Corominas H, Ortiz-Santamaría V, Castellví I, Moreno M, Morlà R, Clavaguera T, Erra A, Martínez-Pardo S, Ordóñez S, Santo P, Reyner P, González MJ, Codina O, Gelman MS, Juanola-Roura X, Olivé A, Torrente-Segarra V, CapiCAT group.
    Rheumatol Int; 2016 Mar 13; 36(3):365-9. PubMed ID: 26597492
    [Abstract] [Full Text] [Related]

  • 40. Blepharospasm, dry eye and extractable nuclear antigen antibodies.
    Girard BC, Abdellaoui M, de Saint Sauveur G, Huang A, Lévy P.
    J Fr Ophtalmol; 2020 Sep 13; 43(7):e211-e215. PubMed ID: 32532571
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.